vs

Side-by-side financial comparison of Organogenesis Holdings Inc. (ORGO) and POWER SOLUTIONS INTERNATIONAL, INC. (PSIX). Click either name above to swap in a different company.

Organogenesis Holdings Inc. is the larger business by last-quarter revenue ($225.6M vs $191.2M, roughly 1.2× POWER SOLUTIONS INTERNATIONAL, INC.). Organogenesis Holdings Inc. runs the higher net margin — 19.4% vs 8.4%, a 11.0% gap on every dollar of revenue. On growth, Organogenesis Holdings Inc. posted the faster year-over-year revenue change (78.1% vs 32.5%). Organogenesis Holdings Inc. produced more free cash flow last quarter ($34.8M vs $-7.6M). Over the past eight quarters, Organogenesis Holdings Inc.'s revenue compounded faster (43.2% CAGR vs 41.7%).

Organogenesis Holdings Inc. is a leading regenerative medicine firm specializing in developing and manufacturing advanced therapeutic products for wound care, surgical repair, sports medicine, and dermatology. It serves healthcare providers and patients primarily in the U.S. and select international markets, offering clinically validated solutions for unmet medical needs.

Adani Energy Solutions Ltd, formerly known as Adani Transmission Ltd, is an electric power transmission and distribution company headquartered in Ahmedabad. As of April 2025, the company operates a cumulative transmission network of 26,696 circuit kilometers and is one of the largest private sector power transmission companies operating in India.

ORGO vs PSIX — Head-to-Head

Bigger by revenue
ORGO
ORGO
1.2× larger
ORGO
$225.6M
$191.2M
PSIX
Growing faster (revenue YoY)
ORGO
ORGO
+45.6% gap
ORGO
78.1%
32.5%
PSIX
Higher net margin
ORGO
ORGO
11.0% more per $
ORGO
19.4%
8.4%
PSIX
More free cash flow
ORGO
ORGO
$42.4M more FCF
ORGO
$34.8M
$-7.6M
PSIX
Faster 2-yr revenue CAGR
ORGO
ORGO
Annualised
ORGO
43.2%
41.7%
PSIX

Income Statement — Q4 FY2025 vs Q4 FY2025

Metric
ORGO
ORGO
PSIX
PSIX
Revenue
$225.6M
$191.2M
Net Profit
$43.7M
$16.1M
Gross Margin
21.9%
Operating Margin
28.1%
12.7%
Net Margin
19.4%
8.4%
Revenue YoY
78.1%
32.5%
Net Profit YoY
469.5%
-31.0%
EPS (diluted)
$0.31
$0.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
ORGO
ORGO
PSIX
PSIX
Q4 25
$225.6M
$191.2M
Q3 25
$150.9M
$203.8M
Q2 25
$101.0M
$191.9M
Q1 25
$86.7M
$135.4M
Q4 24
$126.7M
$144.3M
Q3 24
$115.2M
$125.8M
Q2 24
$130.2M
$110.6M
Q1 24
$110.0M
$95.2M
Net Profit
ORGO
ORGO
PSIX
PSIX
Q4 25
$43.7M
$16.1M
Q3 25
$21.6M
$27.6M
Q2 25
$-9.4M
$51.2M
Q1 25
$-18.8M
$19.1M
Q4 24
$7.7M
$23.3M
Q3 24
$12.3M
$17.3M
Q2 24
$-17.0M
$21.5M
Q1 24
$-2.1M
$7.1M
Gross Margin
ORGO
ORGO
PSIX
PSIX
Q4 25
21.9%
Q3 25
23.9%
Q2 25
28.2%
Q1 25
72.6%
29.7%
Q4 24
75.5%
29.9%
Q3 24
76.7%
28.9%
Q2 24
77.6%
31.8%
Q1 24
73.9%
27.0%
Operating Margin
ORGO
ORGO
PSIX
PSIX
Q4 25
28.1%
12.7%
Q3 25
13.7%
13.9%
Q2 25
-12.5%
16.9%
Q1 25
-30.9%
18.2%
Q4 24
8.1%
17.5%
Q3 24
5.4%
16.3%
Q2 24
-10.7%
22.9%
Q1 24
-3.5%
11.2%
Net Margin
ORGO
ORGO
PSIX
PSIX
Q4 25
19.4%
8.4%
Q3 25
14.3%
13.5%
Q2 25
-9.3%
26.7%
Q1 25
-21.7%
14.1%
Q4 24
6.1%
16.1%
Q3 24
10.7%
13.8%
Q2 24
-13.1%
19.5%
Q1 24
-1.9%
7.5%
EPS (diluted)
ORGO
ORGO
PSIX
PSIX
Q4 25
$0.31
$0.69
Q3 25
$0.11
$1.20
Q2 25
$-0.10
$2.22
Q1 25
$-0.17
$0.83
Q4 24
$0.05
$1.01
Q3 24
$0.09
$0.75
Q2 24
$-0.13
$0.94
Q1 24
$-0.02
$0.31

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
ORGO
ORGO
PSIX
PSIX
Cash + ST InvestmentsLiquidity on hand
$93.7M
$41.3M
Total DebtLower is stronger
$96.6M
Stockholders' EquityBook value
$300.1M
$178.6M
Total Assets
$598.7M
$424.7M
Debt / EquityLower = less leverage
0.54×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
ORGO
ORGO
PSIX
PSIX
Q4 25
$93.7M
$41.3M
Q3 25
$63.7M
$49.0M
Q2 25
$73.1M
$49.5M
Q1 25
$110.0M
$50.0M
Q4 24
$135.6M
$55.3M
Q3 24
$94.3M
$40.5M
Q2 24
$89.9M
$28.8M
Q1 24
$88.6M
$33.1M
Total Debt
ORGO
ORGO
PSIX
PSIX
Q4 25
$96.6M
Q3 25
$96.7M
Q2 25
$1.8M
Q1 25
$1.0M
Q4 24
$184.0K
Q3 24
$62.3M
$238.0K
Q2 24
$63.8M
$292.0K
Q1 24
$65.2M
$345.0K
Stockholders' Equity
ORGO
ORGO
PSIX
PSIX
Q4 25
$300.1M
$178.6M
Q3 25
$255.1M
$162.5M
Q2 25
$233.2M
$135.7M
Q1 25
$242.9M
$84.3M
Q4 24
$262.9M
$65.3M
Q3 24
$278.5M
$42.1M
Q2 24
$263.5M
$24.8M
Q1 24
$278.0M
$3.2M
Total Assets
ORGO
ORGO
PSIX
PSIX
Q4 25
$598.7M
$424.7M
Q3 25
$509.8M
$458.9M
Q2 25
$461.1M
$437.7M
Q1 25
$467.4M
$372.7M
Q4 24
$497.9M
$328.2M
Q3 24
$446.3M
$339.1M
Q2 24
$443.2M
$307.6M
Q1 24
$458.5M
$286.8M
Debt / Equity
ORGO
ORGO
PSIX
PSIX
Q4 25
0.54×
Q3 25
0.60×
Q2 25
0.01×
Q1 25
0.01×
Q4 24
0.00×
Q3 24
0.22×
0.01×
Q2 24
0.24×
0.01×
Q1 24
0.23×
0.11×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
ORGO
ORGO
PSIX
PSIX
Operating Cash FlowLast quarter
$39.4M
$-4.6M
Free Cash FlowOCF − Capex
$34.8M
$-7.6M
FCF MarginFCF / Revenue
15.4%
-4.0%
Capex IntensityCapex / Revenue
2.1%
1.6%
Cash ConversionOCF / Net Profit
0.90×
-0.29×
TTM Free Cash FlowTrailing 4 quarters
$-24.5M
$14.1M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
ORGO
ORGO
PSIX
PSIX
Q4 25
$39.4M
$-4.6M
Q3 25
$3.1M
$3.3M
Q2 25
$-32.9M
$16.7M
Q1 25
$-19.9M
$8.8M
Q4 24
$10.9M
$32.7M
Q3 24
$8.7M
$12.6M
Q2 24
$4.7M
$1.5M
Q1 24
$-10.2M
$15.6M
Free Cash Flow
ORGO
ORGO
PSIX
PSIX
Q4 25
$34.8M
$-7.6M
Q3 25
$844.0K
$1.7M
Q2 25
$-36.5M
$14.6M
Q1 25
$-23.6M
$5.4M
Q4 24
$7.6M
$30.0M
Q3 24
$6.1M
$12.1M
Q2 24
$2.9M
$822.0K
Q1 24
$-12.4M
$14.8M
FCF Margin
ORGO
ORGO
PSIX
PSIX
Q4 25
15.4%
-4.0%
Q3 25
0.6%
0.8%
Q2 25
-36.1%
7.6%
Q1 25
-27.2%
4.0%
Q4 24
6.0%
20.8%
Q3 24
5.3%
9.7%
Q2 24
2.2%
0.7%
Q1 24
-11.3%
15.6%
Capex Intensity
ORGO
ORGO
PSIX
PSIX
Q4 25
2.1%
1.6%
Q3 25
1.5%
0.8%
Q2 25
3.6%
1.1%
Q1 25
4.2%
2.5%
Q4 24
2.7%
1.8%
Q3 24
2.2%
0.3%
Q2 24
1.4%
0.6%
Q1 24
2.0%
0.9%
Cash Conversion
ORGO
ORGO
PSIX
PSIX
Q4 25
0.90×
-0.29×
Q3 25
0.14×
0.12×
Q2 25
0.33×
Q1 25
0.46×
Q4 24
1.43×
1.40×
Q3 24
0.71×
0.73×
Q2 24
0.07×
Q1 24
2.20×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

ORGO
ORGO

Segment breakdown not available.

PSIX
PSIX

Energy End Market$153.4M80%
Industrial End Market$33.3M17%
Transportation End Market$4.6M2%

Related Comparisons